13 on 5 february 2003, the therapeutic goods administration ( tga ), which is part of the department of health and ageing, identified a number of alleged critical deficiencies in pan's compliance with the code and, as a result, a delegate of the secretary imposed a new condition on pan's licence, preventing it from manufacturing certain products.
they rely on the proposition that s 79 of the evidence act does not preclude an expert from generalising from experience in forming an opinion, so long as the expert possesses specialised knowledge and the opinion is wholly or substantially based on that knowledge.
while that may not be fatal to the admissibility of his opinion, it goes very much to the weight of the evidence, if it were admitted.